Cargando…
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
OBJECTIVE: We tested the hypothesis that plasma neurofilament light chain (NfL) identifies asymptomatic carriers of familial frontotemporal lobar degeneration (FTLD)–causing mutations at risk of disease progression. METHODS: Baseline plasma NfL concentrations were measured with single-molecule array...
Ejemplares similares
-
Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
por: Ljubenkov, Peter A., et al.
Publicado: (2018) -
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
por: Asken, Breton M, et al.
Publicado: (2023) -
Peripheral Innate Immune Activation Correlates With Disease Severity in GRN Haploinsufficiency
por: Ljubenkov, Peter A., et al.
Publicado: (2019) -
Longitudinal white matter change in frontotemporal dementia subtypes and sporadic late onset Alzheimer's disease
por: Elahi, Fanny M., et al.
Publicado: (2017) -
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
por: VandeVrede, Lawren, et al.
Publicado: (2023)